Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Millicom International Cellular S.A. Common Stock (TIGO) vs Tilray Brands Inc (TLRY) Price & Performance

Millicom International Cellular S.A. Common StockTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Millicom International Cellular S.A. Common Stock vs Tilray Brands Inc — how do they compare? Millicom International Cellular S.A. Common Stock trades at $80.27 (market cap $13.34B), while Tilray Brands Inc trades at $3.11 (market cap $481.79M). The key difference: Millicom International Cellular S.A. Common Stock is far larger — about 27.7× Tilray Brands Inc's market cap, and Millicom International Cellular S.A. Common Stock pays a 3.77% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Millicom International Cellular S.A. Common Stock for 0 Days and Tilray Brands Inc for 31 Days on average.

TIGOTLRY
Market Cap
$13.34B$481.79M
Volume
1,586,6844,056,443
Sector
MediaHealth
52-Week High
$104.31$16.80
52-Week Low
$45.81$3.14
Typical Hold Time
0 Days31 Days
Enterprise Value
$24.38B$635.71M
Dividend Yield
3.77%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Millicom International Cellular S.A. Common Stock

TIGO trades at $79.54, down 0.92% on the day, with a neutral technical signal and key support at $79. The company reported strong 2025 results with $5.82B revenue and $1.32B net income, but 2026 earnings have missed expectations in two of the last three quarters. Recent news highlights its addition to Zacks' Strong Buy list and a consistent $0.75 quarterly dividend.

The stock offers a 12.9% upside to the consensus price target of $89.78, supported by solid profitability and cash flow, but faces risks from earnings volatility and high debt. Analyst sentiment is mixed with a Hold consensus, suggesting cautious optimism amid integration challenges from recent acquisitions.

Tilray Brands Inc

Tilray Brands (TLRY) trades at $3.27, down 2.68% on the day and near 52-week lows, with bearish technical signals dominating. The company reported $821 million in revenue for 2025 but posted a massive $2.19 billion net loss due to impairment charges. Recent earnings misses and negative cash flow from operations highlight ongoing profitability challenges despite analyst consensus pointing to significant upside potential.

TLRY presents a high-risk opportunity with substantial analyst price target divergence. While valuation metrics appear attractive (P/S 0.4x, P/B 0.3x), persistent losses and cash burn require careful monitoring. The stock's fate hinges on cannabis reform progress and the company's ability to achieve sustainable profitability amid competitive pressures.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TIGO
100% Buy0% Sell
Avg holding period · 0 Days
TLRY
84% Buy16% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About Millicom International Cellular S.A. Common Stock

Millicom International Cellular S.A. operates telecommunications and digital services under the Tigo brand across Latin America, providing mobile, fiber broadband, and pay-TV services. The company also offers mobile financial services through its Tigo Money business.

Read more on TIGO →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →